Evaluation of the ID NOW Among Symptomatic Individuals During the Omicron Wave
Sign Up to like & getrecommendations! Published in 2022 at "Journal of medical microbiology"
DOI: 10.1101/2022.05.19.22275316
Abstract: BACKGROUND Point of Care SARS CoV 2 devices, such as the Abbott ID NOW have great potential, to help combat the COVID19 pandemic. Starting in December, 2020, the ID NOW was implemented throughout the province… read more here.
Keywords: omicron wave; among symptomatic; symptomatic individuals; evaluation among ... See more keywords